Cronos Group 3Q Profit Rises

Dow Jones11-06

By Adriano Marchese

Cronos Group profit rises as cannabis sales in Israel supported revenue growth in the third quarter.

The Canadian cannabinoid company on Thursday reported on Thursday a higher net income of $28.3 million, or 7 cents a share, up from $7.3 million, or 2 cents a share, in the comparable quarter a year ago.

The increase was primarily due to lower amounts of inventory step-up from the Cronos GrowCo transaction recognized into cost of sales. The Cronos Grow transaction was an investment in its joint venture, Cronos Growing Company, to expand cannabis cultivation capacity and support global growth.

Cronos swung to an adjusted earnings before interest, taxes, depreciation and amortization of $5.7 million, from a loss of $6 million a year earlier.

Net revenue rose to $36.3 million from $34.3 million, benefiting from higher cannabis flower sales in Israel, and higher cannabis extract sales in the Canadian. Cannabis flower sales in Canada were lower.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

November 06, 2025 08:16 ET (13:16 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2581095361?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 21:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581095361","market":"fut","top_or_hot":-1,"title":"Cronos Group 3Q Profit Rises","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Cronos Group profit rises as cannabis sales in Israel supported revenue growth in the third quarter. \n</p>\n<p>\n  The Canadian cannabinoid company on Thursday reported on Thursday a higher net income of $28.3 million, or 7 cents a share, up from $7.3 million, or 2 cents a share, in the comparable quarter a year ago. \n</p>\n<p>\n  The increase was primarily due to lower amounts of inventory step-up from the Cronos GrowCo transaction recognized into cost of sales. The Cronos Grow transaction was an investment in its joint venture, Cronos Growing Company, to expand cannabis cultivation capacity and support global growth. \n</p>\n<p>\n  Cronos swung to an adjusted earnings before interest, taxes, depreciation and amortization of $5.7 million, from a loss of $6 million a year earlier. \n</p>\n<p>\n  Net revenue rose to $36.3 million from $34.3 million, benefiting from higher cannabis flower sales in Israel, and higher cannabis extract sales in the Canadian. Cannabis flower sales in Canada were lower. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 06, 2025 08:16 ET (13:16 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cronos Group 3Q Profit Rises</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCronos Group 3Q Profit Rises\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-06 21:16</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Cronos Group profit rises as cannabis sales in Israel supported revenue growth in the third quarter. \n</p>\n<p>\n  The Canadian cannabinoid company on Thursday reported on Thursday a higher net income of $28.3 million, or 7 cents a share, up from $7.3 million, or 2 cents a share, in the comparable quarter a year ago. \n</p>\n<p>\n  The increase was primarily due to lower amounts of inventory step-up from the Cronos GrowCo transaction recognized into cost of sales. The Cronos Grow transaction was an investment in its joint venture, Cronos Growing Company, to expand cannabis cultivation capacity and support global growth. \n</p>\n<p>\n  Cronos swung to an adjusted earnings before interest, taxes, depreciation and amortization of $5.7 million, from a loss of $6 million a year earlier. \n</p>\n<p>\n  Net revenue rose to $36.3 million from $34.3 million, benefiting from higher cannabis flower sales in Israel, and higher cannabis extract sales in the Canadian. Cannabis flower sales in Canada were lower. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 06, 2025 08:16 ET (13:16 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4557","symbol_name":"大麻股","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2581095361","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581095361","pubTimestamp":1762434960,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Cronos Group profit rises as cannabis sales in Israel supported revenue growth in the third quarter.The Canadian cannabinoid company on Thursday reported on Thursday a higher net income of $28.3 million, or 7 cents a share, up from $7.3 million, or 2 cents a share, in the comparable quarter a year ago.The increase was primarily due to lower amounts of inventory step-up from the Cronos GrowCo transaction recognized into cost of sales. The Cronos Grow transaction was an investment in its joint venture, Cronos Growing Company, to expand cannabis cultivation capacity and support global growth.Cronos swung to an adjusted earnings before interest, taxes, depreciation and amortization of $5.7 million, from a loss of $6 million a year earlier.Net revenue rose to $36.3 million from $34.3 million, benefiting from higher cannabis flower sales in Israel, and higher cannabis extract sales in the Canadian. Cannabis flower sales in Canada were lower.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4557":"大麻股","CRON":"Cronos Group Inc.","BK4007":"制药"},"translate_title":"Cronos集团第三季度利润增长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRON":0.9},"content_text":"By Adriano Marchese \n\n\n \n\n\n  Cronos Group profit rises as cannabis sales in Israel supported revenue growth in the third quarter. \n\n\n  The Canadian cannabinoid company on Thursday reported on Thursday a higher net income of $28.3 million, or 7 cents a share, up from $7.3 million, or 2 cents a share, in the comparable quarter a year ago. \n\n\n  The increase was primarily due to lower amounts of inventory step-up from the Cronos GrowCo transaction recognized into cost of sales. The Cronos Grow transaction was an investment in its joint venture, Cronos Growing Company, to expand cannabis cultivation capacity and support global growth. \n\n\n  Cronos swung to an adjusted earnings before interest, taxes, depreciation and amortization of $5.7 million, from a loss of $6 million a year earlier. \n\n\n  Net revenue rose to $36.3 million from $34.3 million, benefiting from higher cannabis flower sales in Israel, and higher cannabis extract sales in the Canadian. Cannabis flower sales in Canada were lower. \n\n\n \n\n\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 06, 2025 08:16 ET (13:16 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2581095361","isCrawlerRequest":true}